Literature DB >> 7507782

Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases.

J I Lopez1, J C Angulo, N Flores, J D Toledo.   

Abstract

OBJECTIVE: To study the clinical, histological, and immunohistochemical findings of small cell carcinoma (SCC) of the urinary bladder, and also to delineate its behaviour in comparison with transitional cell carcinomas of the bladder.
MATERIALS AND METHODS: A retrospective review of 552 patients with bladder cancer yielded six cases (1%) of small cell carcinoma which were histologically identical to pulmonary small cell anaplastic carcinoma. Clinical data and follow-up were collected. Aside from the conventional histological parameters, an immunohistochemical study with AE1-AE3 and Cam 5.2 keratins, epithelial membrane antigen, neuron-specific enolase, chromogranin, synaptophysin, ACTH, calcitonin, and prostatic specific antigen was performed.
RESULTS: The clinical presentation did not differ from conventional transitional cell carcinoma, haematuria being the most frequent complaint (four cases). All the cases presented as flat tumours. On light microscopy, there were oat cell (four cases), intermediate (one case) and mixed oat-cell/intermediate (one case) variants. Three cases were associated with transitional cell carcinoma. Dysplastic changes were observed in the adjacent urothelium in one case only. At the time of diagnosis, all tumours were deeply invasive (pT3). Three cases were Stage III and three Stage IV, with involvement of regional lymph nodes and metastases to the liver (two cases) and lung (one case). Immunohistochemically, epithelial markers were variably expressed as AE1-AE3 keratin (5/6), Cam 5.2 keratin (2/6) and epithelial membrane antigen (3/6). Neuron specific enolase was demonstrated in every case. Chromogranin, however, was expressed in only one case. Synaptophysin, ACTH, calcitonin, and prostatic specific antigen all gave negative results. All the patients died of the disease and the overall length of survival was very poor (range 5-25 months, mean 13.3).
CONCLUSION: Small cell carcinomas show the same histological patterns as their pulmonary counterpart. Immunohistochemistry reveals a wide spectrum of activity, enolase and keratins being the most constant. The present study confirms that the overall prognosis of this tumour is very poor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507782     DOI: 10.1111/j.1464-410x.1994.tb07454.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  13 in total

Review 1.  Small cell carcinoma of the bladder: a case report and review of the literature.

Authors:  Burcin Tunc; Mustafa Ozguroglu; Oktay Demirkesen; Cabir Alan; Haydar Durak; Fazilet Oner Dincbas; Ali Riza Kural
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

2.  Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder.

Authors:  Axel Bex; Remco de Vries; Floris Pos; Martijn Kerst; Simon Horenblas
Journal:  World J Urol       Date:  2008-07-08       Impact factor: 4.226

3.  Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.

Authors:  Ma Jesús Fernández-Aceñero; Sharon Córdova; Félix Manzarbeitia; Camino Medina
Journal:  Pathol Oncol Res       Date:  2011-01-04       Impact factor: 3.201

4.  The oncological outcomes of small cell carcinoma of the bladder.

Authors:  Harley A Williams; Nahid Punjani; Obaidullah Khan; Nicholas E Power
Journal:  Can Urol Assoc J       Date:  2018-12-03       Impact factor: 1.862

5.  Primary small cell neuroendocrine carcinoma of urinary bladder: an uncommon entity to be recognized.

Authors:  G Nabi; I Singh; M S Ansari; M C Sharma; P N Dogra
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases.

Authors:  P Soriano; S Navarro; M Gil; A Llombart-Bosch
Journal:  Virchows Arch       Date:  2004-07-10       Impact factor: 4.064

7.  Clinical outcome of primary small cell carcinoma of the urinary bladder.

Authors:  Chen-Pang Hou; Yu-Hsiang Lin; Chien-Lun Chen; Phei-Lang Chang; Ke-Hung Tsui
Journal:  Onco Targets Ther       Date:  2013-08-26       Impact factor: 4.147

8.  Small Cell Carcinoma of the Urinary Bladder: KIT and PDGFRA Gene Mutations.

Authors:  Nuket Eliyakin; Hakan Postaci; Yasemin Baskin; Zafer Kozacioğlu
Journal:  Rare Tumors       Date:  2015-12-29

9.  Small cell carcinoma of the urinary bladder: CT and MR imaging findings.

Authors:  Jong Chul Kim; Kie Hwan Kim; Seungeun Jung
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

10.  Partial cystectomy in a 76 year old patient suffering from small cell carcinoma of the urinary bladder.

Authors:  Radosław Starownik; Agnieszka Korolczuk; Krzysztof Bar; Paweł Płaza; Jacek Kiś; Kamil Muc; Marek Bar
Journal:  Cent European J Urol       Date:  2013-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.